Global Leaders in
Liposomal Development and Manufacturing
Structured delivery. Controlled manufacturing. Commercial scale.
GMPriority Pharma is a UK-based liposomal CDMO specialising in white label products, contract manufacturing and bulk ingredients.
Operating within GMP-certified, FSSC ISO 22000-accredited facilities, we design and produce lipid-based systems with defined particle characteristics, controlled processing parameters and scalable manufacturing pathways.
From ingredient design
to market-ready products
White label products, contract manufacturing and bulk ingredients – developed and manufactured in the UK using structured liposomal system design and controlled manufacturing approaches.
Our integrated environment combines Class 7 cleanroom production, dedicated R&D laboratories and in-house analytical capability, including particle size distribution and dispersion characterisation.
This allows formulation, scale-up and manufacturing to be aligned from the outset, supporting consistent performance, reduced scale-up risk and reliable commercial supply.
All routes are developed using the same underlying SAIFx® delivery design principles, ensuring consistency across ingredients, formulations and finished products.
Three routes to market.
One liposomal standard.
Structured Ingredient Partnerships
We also support branded and exclusive ingredient collaborations, where liposomal systems are developed or supplied under defined partnership frameworks.
Liposomal Expertise
Built for Real-World Performance
At GMPriority Pharma, every white label product, contract manufacturing programme and bulk ingredient is developed using a consistent, delivery-led framework.
This framework governs how lipid systems are selected, structured and processed; aligning formulation design with particle characteristics, stability behaviour and manufacturing constraints from the outset.
Rather than treating delivery as a downstream optimisation, we integrate formulation design and process control early, supporting reproducibility, controlled scale-up and reliable commercial supply.
This approach is formalised through SAIFx® structured delivery principles and remains embedded within how products are engineered and manufactured.
The result is delivery systems designed to perform consistently across development, scale-up and commercial production, not just under laboratory conditions.
Why GMPriority Pharma
- Defined liposomal system design (SAIFx® framework)
- Controlled manufacturing environments (GMP / FSSC ISO 22000)
- In-house analytical capability (particle size, stability, dispersion)
- Reproducible scale-up from lab to commercial production
Integrated Scientific and
Manufacturing Infrastructure
GMPriority Pharma operates as an integrated liposomal CDMO, combining formulation development, process engineering and in-house manufacturing within a single UK facility.
From early feasibility through to validated commercial productions, programmes are developed within GMP and FSSC ISO 220000 frameworks, supporting controlled, scalable output.
Development is conducted with defined processing parameters and manufacturing constraints in mind, enabling smooth transfer from laboratory to cleanroom without reformulation or process instability.
Our infrastructure includes:
- Class 7 cleanroom manufacturing
- Fully equipped R&D laboratories
- Process-defined scale-up and batch production
- In-house analytical capability including particle size and dispersion characterisation.
This integration reduces technical rick, shortens development timelines and supports reliable commercial supply.
Delivery is designed with manufacturing in mind.
UK-based.
Science-led.
Built for commercial reality.
GMPriority Pharma operates from a fully integrated UK facility, combining scientific development, controlled manufacturing and quality oversight within a single environment.
Our expertise in lipid-based delivery systems is applied within regulated production frameworks, supporting partners from early formulation through to consistent commercial supply.
We work with brands, formulators and ingredient partners who require technical clarity, controlled execution and confidence that what is developed can be manufactured, scaled and supplied reliably.
Flexible Engagement
Consistent Standards
Partners engage with GMPriority Pharma across multiple routes to market, from bulk ingredient supply and structured ingredient collaborations to full-service white label and contract manufacturing programmes.
What remains constant is how liposomal systems are defined, controlled and delivered.
Each programme operates within defined quality frameworks, controlled production environments and transparent development processes, ensuring reliability across scale and format.
Whether supplying ingredients or manufacturing finished products, we prioritise clarity, accountability and execution.
Regardless of route, all programmes operate within the same structured framework, ensuring consistency, transparency and reproducible performance at scale.
Contact us
Whether you require formulation, manufacturing or ingredient supply, we can define the right approach.
